Fulgent Genetics (FLGT) Operating Leases (2019 - 2026)

Fulgent Genetics has disclosed Operating Leases across 7 years of filings, most recently posting $5.6 million for Q2 2026.

• In Q2 2026, Operating Leases rose 48.98% year-over-year to $5.6 million; the TTM figure through Jun 2026 stood at $5.6 million (up 48.98% YoY), while the FY2025 annual figure was $3.8 million, down 8.23% from the prior year.
• Operating Leases came in at $5.6 million for Q2 2026 at Fulgent Genetics, down from $6.0 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $8.8 million in Q4 2022 to a low of $3.6 million in Q3 2025.
• Average Operating Leases over 5 years is $5.4 million, with a median of $5.1 million recorded in 2024.
• Year-over-year, Operating Leases sank 47.38% in 2025 and soared 54.33% in 2026.
• Over 5 years, Operating Leases stood at $8.8 million in 2022, then retreated by 18.74% to $7.1 million in 2023, then plunged by 42.35% to $4.1 million in 2024, then declined by 8.23% to $3.8 million in 2025, then soared by 48.35% to $5.6 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $5.6 million in Q2 2026, $6.0 million in Q1 2026, and $3.8 million in Q4 2025.